P

Protagonist Therapeutics
D

PTGX

102.240
USD
-3.24
(-3.07%)
مغلق
حجم التداول
15,900
الربح لكل سهم
5
العائد الربحي
-
P/E
-56
حجم السوق
6,575,194,776
أصول ذات صلة المقالات
المزيد

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.